Technical Analysis for BEAM - Beam Therapeutics Inc.

Grade Last Price % Change Price Change
C 34.07 -3.80% -1.35
BEAM closed down 3.8 percent on Monday, March 18, 2024, on 66 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup -3.80%
Wide Bands Range Expansion -3.80%
Oversold Stochastic Weakness -3.80%
Fell Below 20 DMA Bearish -1.57%
Stochastic Reached Oversold Weakness -1.57%
Wide Bands Range Expansion -1.57%
Oversold Stochastic Weakness -1.57%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 18 hours ago
Down 3% about 22 hours ago
Rose Above Previous Day's High about 22 hours ago
Down 2 % about 22 hours ago
Down 1% about 22 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Beam Therapeutics Inc., a biotechnology company, engages in developing precision genetic medicines for patients suffering from serious diseases in the United States. It is developing therapies for the development of sickle cell disease and beta-thalassemia; CAR-T cell therapies for pediatric T-cell acute lymphoblastic leukemia and pediatric acute myeloid leukemia; therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1A; and therapies for ocular and central nervous system disorders. The company was founded in 2017 and is based in Cambridge, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Gene Therapy Acute Myeloid Leukemia Leukemia Central Nervous System Disorders Nervous System Disorders Antitrypsin Deficiency Acute Lymphoblastic Leukemia Sickle Cell Disease Acute Leukemia Thalassemia Beta Thalassemia Glycogen Storage Disorder

Is BEAM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 49.5
52 Week Low 16.95
Average Volume 1,409,437
200-Day Moving Average 27.88
50-Day Moving Average 30.98
20-Day Moving Average 36.91
10-Day Moving Average 36.51
Average True Range 2.63
RSI (14) 47.92
ADX 35.85
+DI 25.15
-DI 17.91
Chandelier Exit (Long, 3 ATRs) 41.62
Chandelier Exit (Short, 3 ATRs) 38.56
Upper Bollinger Bands 43.61
Lower Bollinger Band 30.22
Percent B (%b) 0.29
BandWidth 36.29
MACD Line 1.14
MACD Signal Line 1.97
MACD Histogram -0.8297
Fundamentals Value
Market Cap 2.78 Billion
Num Shares 81.5 Million
EPS -4.17
Price-to-Earnings (P/E) Ratio -8.17
Price-to-Sales 29.03
Price-to-Book 3.04
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.60
Resistance 3 (R3) 36.87 36.30 36.18
Resistance 2 (R2) 36.30 35.65 36.16 36.04
Resistance 1 (R1) 35.18 35.25 34.89 34.91 35.90
Pivot Point 34.61 34.61 34.46 34.47 34.61
Support 1 (S1) 33.49 33.96 33.20 33.22 32.23
Support 2 (S2) 32.92 33.56 32.78 32.09
Support 3 (S3) 31.80 32.92 31.95
Support 4 (S4) 31.53